BlackRock Fund Advisors’s Myriad Genetics MYGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $54.4M | Buy |
3,264,023
+473,788
| +17% | +$7.9M | 0.01% | 1626 |
|
|
2016
Q3 | $57.4M | Buy |
2,790,235
+127,246
| +5% | +$2.62M | 0.01% | 1482 |
|
|
2016
Q2 | $81.5M | Sell |
2,662,989
-67,926
| -2% | -$2.08M | 0.02% | 1139 |
|
|
2016
Q1 | $102M | Buy |
2,730,915
+72,034
| +3% | +$2.7M | 0.02% | 938 |
|
|
2015
Q4 | $115M | Sell |
2,658,881
-128,091
| -5% | -$5.53M | 0.03% | 853 |
|
|
2015
Q3 | $104M | Buy |
2,786,972
+59,360
| +2% | +$2.22M | 0.03% | 871 |
|
|
2015
Q2 | $92.7M | Buy |
2,727,612
+1,111,593
| +69% | +$37.8M | 0.02% | 1056 |
|
|
2015
Q1 | $57.2M | Buy |
1,616,019
+135,261
| +9% | +$4.79M | 0.01% | 1423 |
|
|
2014
Q4 | $50.4M | Sell |
1,480,758
-10,017
| -0.7% | -$341K | 0.01% | 1459 |
|
|
2014
Q3 | $57.5M | Buy |
1,490,775
+23,333
| +2% | +$900K | 0.02% | 1270 |
|
|
2014
Q2 | $57.1M | Sell |
1,467,442
-26,886
| -2% | -$1.05M | 0.02% | 1312 |
|
|
2014
Q1 | $51.1M | Buy |
1,494,328
+51,866
| +4% | +$1.77M | 0.02% | 1403 |
|
|
2013
Q4 | $30.3M | Sell |
1,442,462
-15,171
| -1% | -$318K | 0.01% | 1736 |
|
|
2013
Q3 | $34.3M | Buy |
1,457,633
+183,450
| +14% | +$4.31M | 0.01% | 1604 |
|
|
2013
Q2 | $34.2M | Buy |
+1,274,183
| New | +$34.2M | 0.01% | 1478 |
|